Ocrelizumab reccommended for relapsing remitting multiple sclerosis
Ocrelizumab has been recommended by the Scottish Medicines Consortium to treat relapsing remitting multiple sclerosis (RRMS) in adults.
List view / Grid view
News
FDA grants frontotemporal dementia drug Orphan-Drug Designation
A dementia drug has been given Orphan Drug Designation by the FDA, meaning this special status will qualify sponsors of the drug for development incentives...
Increasing dose of statins could save more lives
A study has shown that thousands of heart attacks and deaths caused by cardiovascular disease could be prevented through the use of statins...
Oxybutynin improves quality of life for breast cancer survivors
Oxybutynin could help breast cancer survivors who are affected by increased hot flushes through cancer treatment, improving their quality of life...
‘Record year for pharma packaging and drug delivery innovation’ says Pharmapack
In an all-time record year for FDA approvals (48 so far in 2018), Pharmapack Europe reports that innovation is also accelerating across the drug delivery and packaging industries...
Five more countries to join EMA-FDA mutual recognition
The US FDA has announced that it will confirm the capability of five more countries to carry out good manufacturing practice (GMP)...
CPhI report forecasts India to have strongest global growth in 2019
CPhI & P-MEC India opens as report ranks India the world’s fastest improving pharma market and first for ‘growth potential’ for 2019...
PET tracer able to image tau in Alzheimer’s disease patients
Research into detecting tau proteins in the brains of Alzheimer's patients has shown that a specific tracer could detect and measure the protein levels...
Phase III KATHERINE trial crossed early reporting boundary and met its primary endpoint
A phase III clinical trial showed that neoadjuvant chemotherapy and trastuzumab reduced the risk of recurrence of HER2-positive early-stage breast cancer...
Trastuzumab taken with carvedilol leads to less heart damage
A team of Iranian researchers have determined that trastuzumab taken with a heart drug leads to less heart damage in breast cancer patients...
Rivaroxaban reduced blood clots and related death in cancer patients
Through a clinical trial, Cleveland researchers have identified how rivaroxaban reduces blood clots in cancer patients and also decreases related deaths...
Discovery to save more women in childbirth from postpartum hemorrhaging
The development of a drug that could be used to save women from postpartum hemorrhaging, could save many thousands of women each year...
‘Elastic’ contrast protein for more accurate imaging
Researchers have developed a method of using less contrast medium to still obtain high quality images in magnetic resonance imaging (MRI)...
Global 2-year trial reports on CAR-T therapy to treat DLBCL
A study has reported results of a clinical trial using CAR-T therapy where over half of the cancer patients were alive two years after the start...
Cardiac cells integrated into microneedle patches could treat heart attacks
A tiny microneedle patch could be the future of delivering therapeutic cell related drugs to the heart of patients after a heart attack...
